Vera Therapeutics, Inc. (VERA)
NASDAQ
Market Cap
$1.84B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
70 of 809
Rank in Industry
55 of 445
Largest Insider Buys in Sector
VERA Stock Price History Chart
VERA Stock Performance
About Vera Therapeutics, Inc.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Insider Activity of Vera Therapeutics, Inc.
Over the last 12 months, insiders at Vera Therapeutics, Inc. have bought $5M and sold $59.36M worth of Vera Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Vera Therapeutics, Inc. have bought $44.26M and sold $21.02M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Katabi Maha (director) — $10M.
The last purchase of 161,290 shares for transaction amount of $5M was made by Katabi Maha (director) on 2024‑01‑30.
List of Insider Buy and Sell Transactions, Vera Therapeutics, Inc.
| 2024-05-16 | Sale | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | 20,651 0.037% | $42.32 | $873,890 | -10.00% | |
| 2024-05-15 | Sale | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | 10,186 0.0184% | $42.27 | $430,546 | -11.03% | |
| 2024-04-10 | Sale | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | 5,714 0.01% | $40.00 | $228,560 | -5.03% | |
| 2024-04-03 | Sale | Grant Sean | CHIEF FINANCIAL OFFICER | 118,477 0.2156% | $39.58 | $4.69M | -0.33% | |
| 2024-03-25 | Sale | Katabi Maha | director | 340,000 0.6089% | $40.50 | $13.77M | -3.84% | |
| 2024-03-22 | Sale | Katabi Maha | director | 413,450 0.7439% | $40.51 | $16.75M | -3.35% | |
| 2024-03-21 | Sale | Katabi Maha | director | 81,009 0.1521% | $44.20 | $3.58M | -7.51% | |
| 2024-01-30 | Katabi Maha | director | 161,290 0.3273% | $31.00 | $5M | +19.18% | ||
| 2024-01-10 | Sale | COMMODORE CAPITAL LP | 10 percent owner | 1.05M 2.1892% | $18.00 | $18.9M | +106.66% | |
| 2023-08-21 | Sale | Fordyce Marshall | President and CEO | 5,210 0.0108% | $16.66 | $86,779 | +9.44% | |
| 2023-08-21 | Sale | Curley Joanne | Chief Development Officer | 1,490 0.0031% | $16.66 | $24,817 | +9.44% | |
| 2023-08-21 | Sale | Lin Celia | Chief Medical Officer | 1,490 0.0031% | $16.65 | $24,816 | +9.44% | |
| 2023-06-23 | Grant Sean | Chief Financial Officer | 5,000 0.0128% | $16.60 | $83,000 | +5.39% | ||
| 2023-06-20 | COMMODORE CAPITAL LP | 10 percent owner | 448,217 1.1993% | $15.17 | $6.8M | +20.13% | ||
| 2023-03-30 | SEIDENBERG BETH C | director | 2,300 0.0059% | $7.24 | $16,651 | +109.34% | ||
| 2023-03-28 | SEIDENBERG BETH C | director | 23,908 0.0633% | $7.24 | $173,192 | +114.46% | ||
| 2023-03-27 | SEIDENBERG BETH C | director | 1,633 0.0043% | $7.24 | $11,830 | +113.15% | ||
| 2023-03-24 | SEIDENBERG BETH C | director | 1,833 0.0047% | $7.24 | $13,272 | +105.59% | ||
| 2023-03-20 | SEIDENBERG BETH C | director | 15,252 0.0391% | $7.21 | $110,033 | +105.48% | ||
| 2023-03-17 | SEIDENBERG BETH C | director | 74,045 0.1962% | $7.12 | $526,882 | +111.08% |
Insider Historical Profitability
73.8%
| COMMODORE CAPITAL LP | 10 percent owner | 4400000 8.0121% | $33.72 | 1 | 1 | +20.13% |
| Katabi Maha | director | 2793987 6.6072% | $33.72 | 2 | 3 | +57.41% |
| Fordyce Marshall | President and CEO | 243361 0.4431% | $33.72 | 0 | 9 | |
| Curley Joanne | Chief Development Officer | 26962 0.0491% | $33.72 | 0 | 18 | |
| Young Joseph R | SVP, Finance, Chief Acct Offcr | 51206 0.0413% | $33.72 | 2 | 3 | +91.54% |
| Lin Celia | Chief Medical Officer | 11010 0.02% | $33.72 | 0 | 1 | |
| Grant Sean | Chief Financial Officer | 0 0.0109% | $33.72 | 4 | 1 | +32.83% |
| Sofinnova Venture Partners X, L.P. | 10 percent owner | 3467156 6.3135% | $33.72 | 3 | 0 | +50.66% |
| Abingworth LLP | 10 percent owner | 2960231 5.3904% | $33.72 | 1 | 0 | +57.41% |
| EMSTER KURT VON | director | 2960231 5.3904% | $33.72 | 2 | 0 | +58.05% |
| Carlyle Group Inc. | 10 percent owner | 2960231 5.3904% | $33.72 | 0 | 1 | |
| Carlyle Genesis UK LLC | 2960231 5.3904% | $33.72 | 0 | 1 | ||
| SEIDENBERG BETH C | director | 1949295 3.5495% | $33.72 | 19 | 0 | +96.5% |
| ENRIGHT PATRICK G | 1714285 3.1216% | $33.72 | 3 | 0 | +50.66% | |
| Longitude Capital Partners IV, LLC | 10 percent owner | 1714285 3.1216% | $33.72 | 3 | 0 | +50.66% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Avoro Capital Advisors Llc | $227.03M | 9.63 | 5.26M | New | +$227.03M | 2.72 | |
| BlackRock | $143.11M | 6.07 | 3.32M | +20.48% | +$24.32M | <0.01 | |
| Commodore Capital, LP | $136.47M | 5.79 | 3.17M | -41.93% | -$98.53M | 9.62 | |
| Fidelity Investments | $134.68M | 5.71 | 3.12M | +12.58% | +$15.04M | 0.01 | |
| Sofinnova | $120.48M | 5.11 | 2.79M | -19.42% | -$29.03M | 0.25 | |
| T. Rowe Price | $103.19M | 4.38 | 2.39M | New | +$103.19M | 0.01 | |
| State Street | $101.36M | 4.3 | 2.35M | +7.78% | +$7.32M | <0.01 | |
| The Vanguard Group | $92.65M | 3.93 | 2.15M | +31.53% | +$22.21M | <0.01 | |
| Eversept Partners LP | $78.64M | 3.33 | 1.82M | -4.75% | -$3.93M | 5.92 | |
| Morgan Stanley | $66.27M | 2.81 | 1.54M | +54.48% | +$23.37M | 0.01 | |
| Kynam Capital Management Lp | $65.84M | 2.79 | 1.53M | -58.17% | -$91.57M | 0.83 | |
| Holocene Advisors, LP | $52.06M | 2.21 | 1.21M | New | +$52.06M | 0.19 | |
| Point72 Asset Management | $50.67M | 2.15 | 1.18M | +19.39% | +$8.23M | 0.1 | |
| Geode Capital Management | $41.46M | 1.76 | 961,309 | +22.82% | +$7.7M | <0.01 | |
| Woodline Partners LP | $40.84M | 1.73 | 947,097 | -62.22% | -$67.27M | 0.39 | |
| Adage Capital Partners Gp L L C | $36.1M | 1.53 | 837,195 | New | +$36.1M | 0.07 | |
| Altium Capital Management Lp | $30.62M | 1.3 | 710,000 | +15.45% | +$4.1M | 14.23 | |
| OrbiMed | $29.14M | 1.24 | 675,872 | -55.48% | -$36.32M | 0.6 | |
| Polar Capital | $29.11M | 1.23 | 675,000 | -6.9% | -$2.16M | 0.16 | |
| Samlyn Capital, LLC | $27.83M | 1.18 | 645,501 | New | +$27.83M | 0.49 | |
| Deutsche Bank | $27.47M | 1.16 | 636,994 | +0.52% | +$142,684.08 | 0.01 | |
| D. E. Shaw & Co. | $25.92M | 1.1 | 601,036 | +186.15% | +$16.86M | 0.04 | |
| Readystate Asset Management Lp | $25.62M | 1.09 | 594,091 | New | +$25.62M | 1.43 | |
| Logos Global Management Lp | $24.79M | 1.05 | 575,000 | New | +$24.79M | 2.66 | |
| Goldman Sachs | $24.14M | 1.02 | 559,790 | -13.78% | -$3.86M | 0.01 | |
| Artal Group S A | $21.82M | 0.93 | 506,019 | New | +$21.82M | 0.12 | |
| Marshall Wace | $20.72M | 0.88 | 480,519 | New | +$20.72M | 0.03 | |
| Affinity Asset Advisors | $20.27M | 0.86 | 470,000 | New | +$20.27M | 3.6 | |
| Voloridge Investment Management, LLC | $19.27M | 0.82 | 446,905 | +2,566.34% | +$18.55M | 0.04 | |
| First Light Asset Management | $18.81M | 0.8 | 436,133 | New | +$18.81M | 1.49 | |
| Avidity Partners Management Lp | $16.54M | 0.7 | 383,500 | New | +$16.54M | 0.6 | |
| Northern Trust | $16.06M | 0.68 | 372,454 | +15.73% | +$2.18M | <0.01 | |
| Integral Health Asset Management Llc | $15.52M | 0.66 | 360,000 | New | +$15.52M | 1.54 | |
| Schroder Investment Management Group | $15.16M | 0.64 | 351,653 | -68.35% | -$32.74M | 0.02 | |
| ROCK SPRINGS CAPITAL MANAGEMENT, LP | $14.71M | 0.62 | 341,168 | New | +$14.71M | 0.38 | |
| Charles Schwab | $14.59M | 0.62 | 338,425 | +21.75% | +$2.61M | <0.01 | |
| JPMorgan Chase | $14.47M | 0.61 | 335,564 | +970.55% | +$13.12M | <0.01 | |
| Invesco | $13.26M | 0.56 | 307,610 | +13.78% | +$1.61M | <0.01 | |
| AXA | $11.73M | 0.5 | 272,078 | -28.9% | -$4.77M | 0.04 | |
| Driehaus Capital Management LLC | $11.09M | 0.47 | 257,257 | +276.62% | +$8.15M | 0.11 | |
| Alphabet | $10.4M | 0.44 | 241,264 | -20% | -$2.6M | 0.42 | |
| Lord Abbett | $9.73M | 0.41 | 225,581 | New | +$9.73M | 0.03 | |
| Bank of America | $8.63M | 0.37 | 200,152 | +420.11% | +$6.97M | <0.01 | |
| Rafferty Asset Management Llc | $7.54M | 0.32 | 174,783 | +2.36% | +$173,558.00 | 0.02 | |
| BNY Mellon | $6.7M | 0.28 | 155,468 | +18.39% | +$1.04M | <0.01 | |
| PLATINUM INVESTMENT MANAGEMENT LTD | $6.64M | 0.28 | 153,932 | -23.15% | -$2M | 0.09 | |
| Citigroup | $6.58M | 0.28 | 152,568 | +117.01% | +$3.55M | 0.01 | |
| Nuveen | $6.33M | 0.27 | 146,823 | -25.92% | -$2.21M | <0.01 | |
| Two Sigma | $6.1M | 0.26 | 141,350 | +39.55% | +$1.73M | 0.01 | |
| Wellington Management Company | $5.64M | 0.24 | 130,794 | New | +$5.64M | <0.01 |